M&A Corner
ARTIS Ventures Closes $200M TechBio Fund to Support Next Era of Health & Medicine Innovation18 Dec 2023
ARTIS Ventures launches TechBio II, a $200M fund targeting healthcare and biology innovation. Emphasizing global impact, neglected diseases, and care... Continue Reading
|
Alternative Funding Strategies to Discuss at JPM18 Dec 2023
In navigating the biopharma funding landscape in 2024, the focus lies on a robust financing strategy and compelling storytelling to... Continue Reading
|
Digital twin company Twin Health secures $50M.18 Dec 2023
Twin Health secures $50 million in funding led by Temasek, augmenting its AI-driven Whole Body Digital Twin model targeting metabolic... Continue Reading
|
Battelle Brings Specialized Engineering Capabilities and Clinical Study Expertise to Collaboration with Spark Biomedical on Department of Defense $1.15 Million Grant18 Dec 2023
Battelle and Spark Biomedical collaborate on Sparrow Hawk, a wearable neurostimulation device using tAN® technology to address Acute Stress Reactions... Continue Reading
|
Best Buy Health, Biobeat partner on RPM wearables18 Dec 2023
Biobeat and Best Buy Health collaborate, integrating Biobeat’s wrist and chest monitors into Best Buy’s Current Health platform for remote... Continue Reading
|
Medtronic Expands AI-Driven Partnership with Cosmo Pharmaceuticals to Transform Endoscopy18 Dec 2023
Medtronic deepens AI collaboration with Cosmo Pharmaceuticals, aiming to advance medical AI solutions. The alliance expands the GI Genius™ intelligent... Continue Reading
|
Talkspace Launches Partnership with Evernow for Women’s Health.18 Dec 2023
Talkspace and Evernow form a strategic partnership focusing on women’s mental health during menopause. Talkspace provides therapy services, while Evernow... Continue Reading
|
Ironwood Announces the Completion of Squeeze-Out Merger with VectivBio.18 Dec 2023
Ironwood Pharmaceuticals finalizes the squeeze-out merger with VectivBio under Swiss law, acquiring remaining shares at $17.00 each. After a successful... Continue Reading
|
GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc.18 Dec 2023
GT Medical Technologies acquires Isoray’s Cesium-131 assets to strengthen GammaTile Therapy, targeting brain tumor patients. The deal enhances seed production... Continue Reading
|
Haemonetics Corporation Completes Acquisition of OpSens Inc.18 Dec 2023
Haemonetics, a medical technology firm, completes the acquisition of Opsens Inc. for approximately $255 million. This move bolsters Haemonetics’ hospital... Continue Reading
|